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Birth weightthe role of maternal gestational weight gain (GWG). We used a pooled dataset of 9377 mother–child pairs
enrolled in 14 study populations from 11 European birth cohorts. General additive models were used to
evaluate the shape of the relationships between organochlorine compounds and birth outcomes. We ob-
served an inverse linear exposure–response relationship between prenatal exposure to PCB-153 and
birth weight [decline of 194 g (95% CI −314, −74) per 1 μg/L increase in PCB-153]. We showed effects
on birth weight over the entire exposure range, including at low levels. This reduction seems to be stronger
among children of mothers who were non-Caucasian or had smoked during pregnancy. The most susceptible
subgroup was girls whose mothers smoked during pregnancy. After adjusting for absolute GWG or estimated
fat mass, a reduction in birth weight was still observed. This study suggests that the association between low-
level exposure to PCB-153 and birth weight exists and follows an inverse linear exposure–response relationship
with effects even at low levels, and that maternal smoking and ethnicity modify this association.
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Synthetic organochlorine compounds (OCs) have been extensively
employed for electrical insulators and pesticides until their production
and use were banned in the US in the late 1970s and in Europe in
2001. However, they persist in the environment for many years and
due to their high lipophilicity and biomagnifying properties they are
still being detected in human samples in most parts of the world
(Consonni et al., 2012; Porta et al., 2008). Fetuses and neonates are ex-
posed to these compounds via placental transfer and through
breastfeeding, and due to their relatively immature organs and detoxifi-
cation mechanisms they are considered to be especially vulnerable to
their adverse health effects (Grandjean et al., 2008).
In animal studies, exposure to OCs in utero has been linked to var-
ious adverse effects on the developing fetus, including the nervous,
endocrine, immunologic and reproductive systems (ATSDR, 2000,
2002). In particular, the impact of prenatal polychlorinated biphenyls
(PCBs) and dichlorodiphenyldichloroethylene (p,p′-DDE) exposures
on birth weight and gestational age has been assessed in several epi-
demiological studies due to their steroid-hormone like properties
(reviewed by El Majidi et al., 2012; Toft et al., 2004). Findings are con-
sistent in populations accidentally exposed to high levels of these
compounds but results are not as consistent in groups of the general
population exposed to lower levels (Toft et al., 2004). Results from
previous epidemiological studies examining the association between
prenatal PCBs exposure and birth weight are difficult to compare
due to differences in design, exposure measurement, and background
populations. Further, the “biological concentration–response” rela-
tionship is not clearly established (El Majidi et al., 2012). There is
some evidence that sex of the child and sociodemographic or lifestyle
factors such as education, ethnicity, and smoking may modify the ef-
fect of PCBs on birth outcomes but the potential effect modifiers of
these associations are not well established (Rylander et al., 1995,
1996; Sagiv et al., 2007; Sonneborn et al., 2008). Moreover, it has
been suggested that maternal gestational weight gain (GWG) can
act as confounder of such associations as weight gain may dilute PCB
levels in blood and increase birth weight (Verner et al., 2013), al-
though it can be argued that it may also act as mediator.
In a recent meta-analysis of 7990 mother–child pairs enrolled in 12
European birth cohorts we found an inverse association between low-
level exposure to PCBs and birth weight while no such association was
found for p,p′-DDE (Govarts et al., 2012). The meta-analysis results of
the cohort specific summary statistics, however, did not allow for an ad-
equate modeling of exposure–response relationship or for an appropri-
ate analysis of effect modifiers due to the limited sample size of each
individual cohort. Since the publication of that article, we have obtained
more individual-pollutant level data from the RHEA cohort (Vafeiadi
et al., 2014) and on GWG. Therefore, as an extension of the Govarts
et al. (2012) study, we pooled the datasets to obtain a unique dataset
of these European birth cohorts to: i) examine exposure–response rela-
tionship between PCB-153 and p-p′-DDE and selected birth outcomes;
ii) to evaluate whether any no exposure–effect level and susceptiblesubgroups exist; and iii) to assess the potential confounding from
GWG in such associations.
2. Materials and methods
2.1. Participating cohorts and data collection
The 12 European birth cohorts included in the previous analysis
(Govarts et al., 2012) were invited to participate in this new study con-
ducted within the CHICOS project (Developing a Child Cohort Research
Strategy for Europe — www.chicosproject.eu). Eleven birth cohorts ac-
cepted to participate in the analysis. The population sample was re-
stricted to live-born singleton births with known concentrations of
PCB-153 and/or p,p′-DDE measured in maternal serum/whole blood,
cord serum/plasma, or breastmilk. A data transfer agreement document
was signed by each cohort and datasets were transferred to CREAL
(Centre for Research in Environmental Epidemiology) with personal
identifiers removed using a Secure File Transfer Protocol. Informed con-
sent was obtained from all study participants as part of the original
studies and in accordance with each study's institutional review
board. Each dataset was checked for inconsistencies and completeness.
In this new study, the ELFE pilot cohort did not participate and the
RHEA cohort provided more samples than in the initial study (n =
1115 (Vafeiadi et al., 2014); n = 30 (Govarts et al., 2012)). Finally, a
total of 14 study populations from 11 birth cohorts were included in
the analyses resulting in 9377 mother–child pairs: 9011 of them with
PCB-153 measurements and 8853 with p-p′-DDE measurements. A de-
tailed description of the participating birth cohorts can be found in
Table 1 of Govarts et al. (2012).
2.2. PCB-153 and p,p′-DDE exposure assessment
PCB-153 and p,p′-DDE compounds were selected for the analysis;
PCB-153 because it is a good marker of overall exposure to PCBs
(Hagmar et al., 2006), and p,p′-DDE because it is the most persistent
of the DDT metabolites (ATSDR, 2002). Since cord serum is considered
the best proxy of OC exposure during fetal life (Korrick et al., 2000),
we estimated the equivalent concentrations in cord serum from the
concentrations measured in maternal serum/whole blood or breast
milk. While the Govarts et al. (2012) analyses used general conversion
factors, obtained from literature [see Supplemental material of Govarts
et al. (2012)], for this study we calculated cohort-specific conversion
factors using paired cord and maternal measurements (serum or milk)
of PCB-153 and p,p′-DDE in cohorts where these measurements were
available (FAROES3, INMA, GRD, and PCB cohort) (Supplemental mate-
rial, p. 1–5 and Table S1). For cohorts without available paired mother–
child measurements we applied the cohort-specific conversion factor of
the geographically nearest cohort. In the case of HUMIS, with no avail-
able paired mother–child samples, and Duisburg, with no available
non-lipid adjusted concentrations, we applied the conversion factors
from Govarts et al. (2012). Non-lipid adjusted concentrations of PCB-
153 and p,p′-DDE were used in all the analyses.
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We assessed gestational age (weeks) and birth weight (grams)
obtained from clinical records. Gestational age calculation was based
on the last menstrual period or ultrasound measurements. In some
cohorts, when both estimations differed by more than 7–14 days, the
last menstrual period measurement was replaced by ultrasound deter-
mination (Supplemental material, Table S2). We considered in analysis
the same covariates as in previous analysis by Govarts et al. (2012)
including maternal age, education, ethnicity, and smoking and alcohol
consumption habits during pregnancy, and with the same categoriza-
tion (Supplemental material, Table S2). Preterm birth was defined as
birth before 37 completed weeks of gestation. Maternal GWG (kg)
was extracted from prenatal records or based on mother's recall (Sup-
plemental material, Table S3). Absolute GWG was determined by
subtracting pre-pregnancy weight from the weight in late pregnancy
and fat mass was estimated as a function of GWG (Butte et al., 2003)
(Supplemental material, Table S3). For maternal education and ethnici-
ty, cohort-specific categories were standardized to create common var-
iables: low/medium/high education (Supplemental material, Table S4),
and Caucasian/non-Caucasian (non-Caucasian included: Roma, Inuit,
Latin American, Asian, Eastern European, and African).2.4. Statistical analysis
PCB-153 and p,p′-DDE concentrations below the limit of detection
(LOD) or quantification (LOQ)were replaced by the LOD or LOQ (specif-
ic for each cohort) divided by the square root of two (Hornung and
Reed, 1990). Multiple imputation of missing values for the covariates
was performed using chained equations where 10 completed datasets
were generated, and analyzed using the standard combination rules
for multiple imputations (Spratt et al., 2010). A different imputed
dataset was generated for each of the exposure–outcome relationships
(Supplemental material, Table S5).
Directed acyclic graphs (DAGs) (Shrier and Platt, 2008)were used to
visualize the complex relationships between covariates that may influ-
ence the association between OC and birth weight and to select the co-
variates retained in the final regression models (PCB-153 and birth
weight DAG, Supplemental Fig. S1). The minimal sufficient adjustment
set estimated by the DAGs included cohort, maternal age, maternal ed-
ucation, maternal ethnicity, maternal pre-pregnancy BMI, maternal
smoking in pregnancy, parity, and GWG. Because maternal ethnicity
was not available in FLEHSI but in cohorts where available it did not
modify the association (data not shown), this variable was not included
into the model. Only seven cohorts had data available on GWG and we
tested its influence in the final model only in a sensitivity analysis. We
have further included in the final models the time of sample collection
covariate as a predictor of the OC exposure and the covariates of gesta-
tional age, child's sex, and maternal height as predictors of birth weight
with the aim to increase the precision of the linear regression effect es-
timates (Supplemental Fig. S1).
General additive models (GAMs)were used to evaluate the shape of
the relationships between our exposure–outcome relationships. Linear
mixed models were used to estimate the association between cord
serum OC concentrations and birth weight or gestational age (pooled
analysis). First, unadjusted models were fitted and then models includ-
ing all the selected confounders from theDAGswerefitted. In the case of
PCB-153, 99% of the population had concentrations below 1180 ng/L;
therefore, the aforementioned analyses were repeated excluding those
subjects with extreme values (n = 90 ≥ 1180 ng/L) (Supplemental
material, Fig. S2). The multivariate linear mixed models were also per-
formed comparing quintiles of OC concentrations and calculating the
linear test for trend across them. We used random-effects models
including cohort and PCB-153 or p,p′-DDE as random effects and all
other covariates as fixed effects. Finally, the overall summary effect ofthe individual cohorts was estimated using meta-analysis to check the
consistency with Govarts et al. (2012).
Effect modification by child's sex, maternal pre-pregnancy BMI,
GWG categories, maternal education, maternal ethnicity (FLEHSI not
included), maternal smoking during pregnancy, maternal alcoholic
beverages during pregnancy, time of sample collection, and geographi-
cal region (Northern–Western cohorts vs Southern–Eastern cohorts)
was assessed through inclusion of the interaction terms in the models
(statistically significant effect modification if p-value b 0.05) and strati-
fied analyses.
Various sensitivity analyses were performed to assess the robust-
ness of our results. First, we repeated the analysis leaving one popula-
tion out at the time. Second, for cohorts with no available paired cord
and maternal measurements (Greenland, Warsaw, Kharkiv and
RHEA) we repeated the analyses taking another cohort-specific con-
version factor (Supplemental material, p. 1–5 and Table S1). Third,
we performed the analysis applying the non-cohort specific conver-
sion factors used by Govarts et al. (2012). Fourth, we restricted the
analysis to term births and also used lipid-adjusted and log-
transformed OC concentrations. Furthermore, because PCB-153 and
p,p′-DDE levels were highly correlated (Spearman correlation coeffi-
cients: 0.33 to 1.00, p b 0.001) we adjusted the PCB-153 models for
p,p′-DDE and vice versa to differentiate the role of each pollutant. Fi-
nally, to test whether the relationship between prenatal PCB exposure
and birth weight was attributable to GWG, acting as confounder or
mediator, we adjusted the model for absolute GWG or estimated fat
mass in cohorts where data were available (FLEHSI, HUMIS, INMA
cord, INMA mat, PCB cohort, PÉLAGIE, and RHEA) (Supplemental ma-
terial, Table S3). All statistical analyses were conducted with Stata
12.0 statistical software (Stata Corporation, College Station, Texas).
DAGs were analyzed using the DAGitty version 2.0 (Textor et al.,
2011). All analyses were performed using the imputed datasets ex-
cept the GAM and effect modification analyses where the non-
imputed datasets were used.
3. Results
The mean birth weight and gestational age were 3377 g (standard
deviation (SD): 506) and 39.4 weeks (SD: 1.5), respectively (Supple-
mental material, Table S2). The proportion of preterm births ranged
from 1.5% (FAROES3) to 11.7% (RHEA) and of low birth weight babies
from 0% (FAROES2) to 6.6% (DUISBURG). The percentage of over-
weight/obese women exceeded 30% in HUMIS, Greenland, and RHEA.
The proportion of lower educated women was higher in Greenland
and Kharkiv compared to the other cohorts. Most of the mothers in
each cohort were Caucasian and did not smoke during pregnancy ex-
cept in Greenland where all mothers were Inuit and more than 70%
smoked during pregnancy (Supplemental material, Table S2). The me-
dian OC concentrations in the 14 study populations ranged from 15 to
394 ng/L for PCB-153 (combined median: 100.0 ng/L) and from 50 to
1323 ng/L for p,p′-DDE (combined median: 447.2 ng/L) (Table 1).
Neither PCB-153 nor p,p′-DDE was associated with gestational age
(Supplemental material Table S6). The analysis showed an inverse
linear relationship between prenatal PCB-153 concentrations and
birth weight (Supplemental material, Fig. S3; p-value b 0.001). The
GAM only needed one degree of freedom, i.e. the function fitted by
themodel was linear. The unadjusted pooled analysis showed a statis-
tically significant inverse association between cord serum PCB-153
concentrations and birth weight [β = −0.23 (95% CI: −0.37,
−0.08) per 1 ng/L PCB-153 increase], equivalent to a 225 g reduction
(95% CI:−371,−78) of birthweight per 1 μg/L increase in cord serum
PCB-153 (data not shown). After adjustment the coefficient declined
to 194 g reduction (95% CI:−314,−74) of birth weight per 1 μg/L in-
crease in cord serum PCB-153 (Table 2). A statistically significant
trend (p-value b 0.001) was also shown after comparing quintiles of
PCB-153 concentrations (data not shown). When excluding the 1%
Table 1
Concentration of exposure biomarkers PCB-153 and p,p′-DDE (ng/L) in cord serum (original and obtained by conversion).
Cohort Matrix PCB-153a p,p′-DDEa
N Mean ± SD Median p25 p75 N Mean ± SD Median p25 p75
DUISBURGb MW 227 132.9 ± 88.6 115.2 79.2 172.8 227 284.3 ± 365.5 194.4 126.0 295.2
FAROES2b MS 173 526.9 ± 469.4 394.4 214.3 664.8 173 1862.8 ± 1557.8 1322.8 848.2 2284.6
FAROES3b BM 587 405.4 ± 362.1 310.7 194.7 507.6 587 711.1 ± 792.6 502.2 295.5 829.5
FLEHSI CP 1061 73.3 ± 56.7 60.0 30.0 104.3 1107 316.4 ± 346.2 220.0 131.8 378.1
GRD CP/CS 523 170.6 ± 99.7 150.0 110.0 210.0 – – – – –
HUMISb BM 418 43.2 ± 19.9 39.3 30.7 51.1 418 74.6 ± 109.8 49.9 34.6 79.9
INMA cord CS 1254 157.3 ± 113.5 135.2 91.0 193.6 1559 1409.3 ± 2350.7 603.0 307.3 1509.9
INMA matb MS 868 106.7 ± 69.9 93.8 62.4 134.2 869 395.2 ± 1549.8 198.7 124.7 311.9
Greenlandb MS 546 206.8 ± 278.7 126.4 69.8 233.3 546 694.8 ± 749.2 477.1 261.7 843.7
Warsawb MS 199 17.7 ± 13.9 15.3 8.4 23.8 199 857.6 ± 539.0 695.5 499.0 1096.8
Kharkivb MS 575 34.8 ± 27.7 28.2 18.2 43.7 575 1145.2 ± 794.2 952.6 673.9 1329.1
PCB cohort CS 1055 392.5 ± 456.3 271.4 169.8 448.1 1055 1325.2 ± 1328.2 1015.3 556.7 1667.8
PÉLAGIE CS 396 126.1 ± 77.7 110.0 75.0 160.0 395 253.3 ± 335.8 180.0 98.0 300.0
RHEAb MS 1115 57.5 ± 41.6 47.4 32.2 71.7 1115 932.5 ± 1092.6 623.6 361.1 1103.3
Combined CS 8997 166.6 ± 251.7 100.0 47.4 190.0 8825 846.8 ± 1410.2 447.2 200.0 1000.0
Abbreviations: BM: breast milk; CS: cord serum; CP: cord plasma; MS: maternal serum; MW: maternal whole blood; SD: standard deviation; p: percentile. The INMA cohort was repre-
sented by two (INMA cord and INMAmat) because OCswere determined in differentmatrices. The INUENDO cohortwas divided into three populations: Greenland, Kharkiv andWarsaw.
The PCB cohort included Michalovce and Svidnik.
a Calculated based on datasets on PCB-153 or p,p′-DDE and birth weight (Supplemental Material, Table S4).
b See Supplemental Material, p. 1–5 and Table S1 for more information on conversions from maternal serum/whole blood and breast milk to cord serum concentrations.
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those below 1180 ng/L, the analysis also showed an inverse linear re-
lationship (Fig. 1; p-value: 0.001) and the reduction in birth weight
appeared to be slightly stronger [−215 g (95% CI: −349, −81)]
(Table 2). The GAM showed effects on birth weight over the entire
exposure range, even at low levels. The meta-analysis including all
PCB-153 concentrations showed a reduction in birth weight of
−171 g per 1 μg/L PCB-153 (95% CI:−271,−70) (Table 2 and Sup-
plemental material, Fig. S4). No association was found between cord
serum p,p′-DDE concentrations and birth weight (Table 2).
Further analyses showed evidence for interactions between
some covariates and the PCB-153 association on birth weight
(Table 3). The greatest reductions were found in non-Caucasian
mothers (p-interaction b 0.001) and smokers (p-interaction b 0.001).
Even though the interaction was not significant, girls and the highest
education strata showed the greatest reduction in birth weightTable 2
Adjusted regression coefficients (β — 95% Confidence Interval) of cord serum PCB-153 and p,p
Cohort PCB-153
N A
DUISBURG 227 −
FAROES2 173 −
FAROES3 587 −
FLEHSI 1061 −
GRD 523 −
HUMIS 418 −
INMA cord 1254 −
INMA mat 868 −
Greenland 546 −
Warsaw 199 −
Kharkiv 575
PCB cohort 1055 −
PÉLAGIE 396 −
RHEA 1115 −
Combined effect — pooled analysis (multiple imputation) 8997 −
Excluding high concentrationsb 8907 −
Combined effect — pooled analysis (complete case) 8512 −
Excluding high concentrationsc 8427 −
Combined effect — meta-analysis (multiple imputation) 8997 −
Greenland, Kharkiv and Warsaw are part of the INUENDO cohort.
a Adjusted for cohort, maternal age at delivery, parity, child's sex, maternal pre-pregnancy B
sample collection, gestational age, and the square of gestational age. Cohort and PCB-153 or p,
b PCB-153 concentrations ≥ 1180 ng/L (n = 90); p,p′-DDE concentrations ≥ 6050 ng/L (n
c PCB-153 concentrations ≥ 1180 ng/L (n = 85); p,p′-DDE concentrations ≥ 6050 ng/L (n(Table 3). There was no indication of modification of the PCB-153 effect
on birth weight by maternal weight status, GWG categories, time
of sampling collection, and geographical distribution of cohorts
(Table 3). Given these results, we explored the following two-
way interactions: i) smoking × sex, ii) smoking × education, and iii)
sex × education. We did not explore the two-way interaction of
the ethnicity variable with other covariates due to the high het-
erogeneity of the non-Caucasian group. Significant interactions
(p-interaction b 0.05)were shown for smoking × sex and smoking × ed-
ucation. Therefore, we examined three-way interactions between
the PCB-153 effect and each of these two-way interactions. The
three-way interaction PCB-153 × smoking × sex resulted
borderline statistically significant (p-interaction = 0.06) and
the interaction of PCB-153 × smoking × education was statisti-
cally significant (p-interaction = 0.01). The greatest reduction
in birth weight was shown among girls born from smoking′-DDE (ng/L) with birth weight (g).
p,p′-DDE
djusteda β (95% CI) N Adjusteda β (95% CI)
0.817 (−1.596,−0.038) 227 −0.081 (−0.260, 0.098)
0.063 (−0.203, 0.076) 173 −0.016 (−0.057, 0.025)
0.038 (−0.133, 0.057) 587 −0.021 (−0.065, 0.022)
0.658 (−1.108,−0.207) 1107 0.037 (−0.030, 0.104)
0.391 (−0.760,−0.022) – –
1.034 (−3.455, 1.388) 418 −0.149 (−0.558, 0.260)
0.362 (−0.556,−0.168) 1559 −0.008 (−0.017, 0.001)
0.006 (−0.395, 0.383) 869 0.012 (−0.004, 0.028)
0.218 (−0.371,−0.065) 546 −0.058 (−0.114,−0.001)
0.149 (−4.895, 4.597) 199 −0.101 (−0.214, 0.012)
0.874 (−0.236, 1.983) 575 0.015 (−0.023, 0.054)
0.042 (−0.093, 0.010) 1055 −0.018 (−0.037, 0.000)
0.364 (−0.901, 0.172) 395 0.014 (−0.099, 0.127)
0.305 (−0.928, 0.317) 1115 −0.016 (−0.037, 0.005)
0.194 (−0.314,−0.074) 8825 −0.009 (−0.019, 0.007)
0.215 (−0.349,−0.081) 8737 −0.010 (−0.025, 0.045)
0.174 (−0.280,−0.068) 8035 −0.008 (−0.019, 0.004)
0.196 (−0.314,−0.079) 7988 −0.012 (−0.025, 0.014)
0.171 (−0.271,−0.070) 8825 −0.008 (−0.019, 0.003)
MI, maternal height, maternal smoking during pregnancy, maternal education, time of
p′-DDE were included as random effects.
= 88).
= 47).
Fig. 1. General additive models of the association between cord serum PCB-153 (ng/L) and birth weight (g) (n = 8427). The continuous line is the smoothed function for PCB-153 and
discontinuous lines are the 95% CIs. Adjusted for maternal age at delivery, parity, child's sex, maternal pre-pregnancy BMI,maternal height, maternal smoking during pregnancy,maternal
education, time of sample collection, gestational age, and the square of gestational age. Cohort and PCB-153 were included as random effects. Complete case analysis excluding PCB-153
concentrations ≥ 1180 ng/L. GAM model only needs 1 degree of freedom, i.e. the function fitted by the model is linear.
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smoking:−0.148; Boys/Maternal smoking:−146.43; Girls/Maternal
non-smoking:−141.03; Girls/Maternal smoking:−228.19) (Fig. 2).
The association between PCB-153 and birth weight did not change
after leaving out one population each time (data not shown). Results
did not change substantially when another cohort-specific conversion
factor was taken for Greenland, Warsaw, Kharkiv, and RHEA, and after
applying the conversion factors used by Govarts et al. (2012) (data
not shown). Restricting the analysis to term births did not change the
coefficient. Associations were also comparable when modeling lipid-
adjusted and log-transformed PCB-153 concentrations. When p,p′-
DDE was included in the model, the beta coefficient for the PCB-153
association did not change (data not shown). Adjustment for absolute
GWG or estimated fat mass in cohorts where available [equivalent
pooled analysis n = 4266: −260 g (95% CI: −470, −50)], reduced
the coefficient for PCB-153 by 48% [−135 g (95% CI: −298, 27)] and
34% [−182 g (95% CI:−363,−0)] (Supplemental material Table S7),
respectively.
4. Discussion
This study suggests that there is an inverse linear exposure–
response relationship between prenatal exposure to PCB-153 and
birth weight in a sample of more than 9000 pregnant women of 11
birth cohorts in Europe. This reduction in birth weight related to
PCB-153 exposure seems to be stronger among children of mothers
who were non-Caucasian or had smoked during pregnancy. We also
identified that girls whose mothers smoked during pregnancy were
the most susceptible subgroup. In addition, we found that although
GWG may potentially confound the association between PCB-153
and birth weight, we still saw a large reduction in birth weight withan increase in PCB-153 levels. Infants with low birth weight, generally
defined as a weight below 2500 g, have an increased risk of morbidity
andmortality in the first year of life and an increased risk of cardiovas-
cular and other diseases later in life (Barker, 2007; Elgen et al., 2002;
Iliadou et al., 2004; McCormick, 1985); therefore, our results may
have public health implications for infant and later adult health.
The impact of prenatal PCB exposure on birthweight has been inves-
tigated in nearly 20 studies (ElMajidi et al., 2012). ElMajidi et al. (2012)
performed a systematic analysis of all these studies to verify the plausi-
bility of a causal relationship between PCB exposure and low birth
weight. First, they standardized PCB concentrations per kg of lipids in
maternal plasma and afterwards, they compared ‘standardized biologi-
cal concentration–birth weight’ relationship across studies by applying
the Bradford Hill criteria (Hill, 1965). They concluded that it is unlikely
that PCBs at current exposure levels in the European population are as-
sociated with low birth weight (b2500 g). However, the lack of harmo-
nization of PCB concentrations (i.e. different methods, matrices, units),
the measurement of different congeners among cohorts, and the small
study population size (a thousand subjects the largest) may explain
why this relationship could not be demonstrated. In our large study,
with measurements of the same PCB congener in all cohorts, and
using cohort-specific conversion factors to compare between matrices,
we identified an inverse linear exposure–response relationship. We
have to consider, however, that due to the high uncertainty of the esti-
mate at the end of exposure distribution (n=90 PCB-153≥ 1180 ng/L),
it is difficult to make conclusions at this high level of exposure. Our
meta-analysis results were consistent with those reported by Govarts
et al. (2012). We also found no indications that fetal exposure to PCB-
153 was related to gestational age. In contrast, Kezios et al. (2012)
found evidence of a reduction in gestational age associated with prena-
tal PCBs exposure. This study included 600 Californian pregnantwomen
Table 3
Effect modificationa (β— 95% Confidence Interval) of the association between cord serum
PCB-153 (ng/L) and birth weight (g).
Characteristics N Adjustedb β (95% CI) p for
interaction
Base model
PCB-153 and birth weight
(complete case)
8512 −0.174 (−0.280,−0.068) –
Effect modifiers
Child's sex 0.069
Boy 4413 −0.119 (−0.256, 0.019)
Girl 4099 −0.157 (−0.258,−0.056)
Maternal pre-pregnancy BMI 0.193
b25 kg/m2 6393 −0.128 (−0.218,−0.039)
≥25 kg/m2 2119 −0.213 (−0.408,−0.019)
Gestational weight gainc 0.099
Low 1037 −0.168 (−0.445, 0.108)
Recommended 1657 0.035 (−0.058, 0.128)
High 1572 −0.118 (−0.350, 0.114)
Maternal education 0.006
Low 1897 −0.121 (−0.213,−0.029)
Medium 3966 −0.124 (−0.207,−0.041)
High 2649 −0.185 (−0.386, 0.016)
Maternal ethnicityd b0.001
Caucasian 6666 −0.104 (−0.198,−0.010)
Non-Caucasian 799 −0.199 (−0.312,−0.087)
Maternal smoking during
pregnancye
b0.001
No 6427 −0.095 (−0.179,−0.011)
Yes 2085 −0.204 (−0.339,−0.068)
Maternal alcoholic beverages
during pregnancyf
0.598
No 6379 −0.144 (−0.239,−0.049)
Yes 1838 −0.174 (−0.353, 0.005)
Time of sample collection 0.056
1st trimester 759 0.133 (−0.281, 0.546)
2nd trimester 698 −0.311 (−0.518,−0.105)
3rd trimester 2808 −0.037 (−0.083, 0.009)
Postnatal 4247 −0.274 (−0.450,−0.098)
Geographical regiong 0.667
Northern–Western cohorts 3377 −0.194 (−0.337,−0.050)
Southern–Eastern cohorts 5135 −0.164 (−0.322,−0.006)
Abbreviations: BMI: body mass index; GWG: Gestational Weight Gain.
a Complete case analysis.
b Adjusted for cohort, maternal age at delivery, parity, child's sex, maternal pre-preg-
nancy BMI, maternal height, maternal smoking during pregnancy, maternal education,
time of sample collection, gestational age, and the square of gestational age. Cohort and
PCB-153 were included as random effects.
c Pooled analysis (complete case) for the subset of populationwith GWG data available
(N = 4266):−0.260 (95% CI:−0.470,−0.050).
d Information on ethnicity was not available in FLEHSI. Pooled analysis (complete case)
for the subset of population with ethnicity variable available (N = 7465):−0.156 (95%
CI:−0.256,−0.055).
e Smokers were included in one category (≤10 cigarettes/day + N10 cigarettes/day).
Pooled analysis (complete case) for 2 categories of smoking (no/yes):−0.192 (95% CI:
−0.308,−0.079).
f Pooled analysis (complete case) for the subset of population with alcohol consump-
tion data available (N = 8217):−0.165 (95% CI:−0.269,−0.060).
g Northern–Western cohorts: DUISBURG, FAROES2, FAROES3, FLEHSI, Greenland, GRD,
and HUMIS; Southern–Eastern cohorts: INMA cord, INMAmat, Kharkiv, Warsaw, PCB co-
hort, PÉLAGIE, and RHEA.
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tration of 650 ng/L. Our larger population, including pregnant women
enrolled after 1990 and with lower PCB-153 concentrations than
those reported in Kezios et al. (2012) (median: 100 ng/L) may explain
the different results.
The biological activities of PCBs have been reported to include both
estrogenic and antiestrogenic effects in various in vitro and in vivo
models (Bonefeld-Jorgensen et al., 2001; Pliskova et al., 2005). Estro-
genic activity of PCB-153 could potentially be the underlying mecha-
nism that explains the reduction in birth weight shown here
(Welshons et al., 2003). Moreover, there is some evidence that PCB
can perturb thyroid function (Takser et al., 2005) but it is still not clearwhether this is the mechanism that can impact fetal development
(Kezios et al., 2012). We were unable to identify any exposure level at
which there was no effect on birth weight; but we have to consider
that the GAM analysis might just not be sensitive enough to detect de-
viations, particularly at low doses. The concept of a ‘dose-threshold’,
however, as a dose below of which the effect is assumed to be zero, is
losing support since toxicologists claim that it is impractical since zero
effects cannot be determined (Slob, 2007). They state that it is more ap-
propriate to estimate the point of departure index, derived from the
benchmark dose approach and equivalent to the dose where the effect
is below some effect size (Slob, 2007). Further studies assessing the ex-
posure–response association between OCs and birth outcomes might
address this issue, as has been done for intellectual impairment
(Jacobson et al., 2002). It should be noted however, that although
PCB-153 represents nearly 28% of total PCBs (Hagmar et al., 2006), the
exposure–response relationship described here may not apply for
other PCB congeners (Bonefeld-Jorgensen et al., 2001; Connor et al.,
1997; Kraugerud et al., 2010). Moreover, the estrogenic potency of
PCB-153 is 103–104 times weaker than estradiol (Bonefeld-Jorgensen
et al., 2001). If the effect shown here is indeed explained by the estro-
genic activity of PCB-153, then it is unlikely that only the measured
PCB-153 concentrations can elicit the observed response unless many
PCB congeners and related compounds act in concert with additive or
synergistic effects, as it has been demonstrated in some animal studies
(Christiansen et al., 2012).
A stronger effect of environmental toxicants on birth weight
among smokers has also been reported for PCBs (Rylander et al.,
1995; Sagiv et al., 2007) and hexachlorobenzene (HCB) (Eggesbo
et al., 2009). Cigarette smoking contains a number of toxins that can
cause cellular damage and disrupt immune function (Noakes et al.,
2003), but the biological mechanisms for the modifying effect of
smoking remain unknown. Further analysis in our population allowed
us to identify a PCB–smoking–sex interaction and newborn girls
whose mothers smoked during pregnancy appeared to be the most
susceptible subgroup. Although the two way interaction between
PCB-153 and sex was not significant, girls seemed to be more affected
by the effect of PCB-153 on birth weight than boys. This contradicts
most of the publications reporting sex-specific results frequently indi-
cating a stronger reduction in boys (Hertz-Picciotto et al., 2005;
Rylander et al., 1995, 1996; Tsukimori et al., 2012). However, these
studies used fish consumption as an indicator of exposure to PCBs
during pregnancy (Rylander et al., 1995, 1996) or had a modest sam-
ple size [n = 399 (Hertz-Picciotto et al., 2005) and n = 101
(Tsukimori et al., 2012)]. On the contrary, some studies investigating
the obesogenic effects of prenatal PCB exposure have indicated a
higher risk of overweight in girls (Gladen et al., 2000; Lamb et al.,
2006; Valvi et al., 2012). Children with lower weight at birth tend to
growth faster during the first years of life than children with higher
birth weights and they are at higher risk of obesity later in childhood
and adult life (Baird et al., 2005; Labayen et al., 2012; Ong et al., 2000).
Thus, the increased risk in girls for childhood obesity linked to prena-
tal PCB exposure may be mediated, at least partially, by the greatest
reduction in birth weight among girls shown here. However, the bio-
logical mechanisms underlying the possible interaction between PCB-
153 and sex remain to be established. Besides, the reason why coexis-
tence of these two factors (girls and maternal smoking) may increase
the PCB effect susceptibility needs to be further explored.
Non-Caucasian mothers including Inuit (100% Greenland),
Romanian (21.0% PCB cohort), Latin American (3.0% INMA mat and
cord), African (0.4% DUISBURG), Asian/Eastern European (3.1% DUIS-
BURG), and Asian (1.9% HUMIS) had a greater PCB-associated reduction
in birth weight than Caucasian mothers. Since individual interactions
per cohort did not reach the level of statistical significance (data not
shown), we did not investigate whether this high susceptibility was
for the overall group of non-Caucasian or only for some specific sub-
groups. This race vulnerability to PCB effects has been suggested in
Fig. 2. General additivemodels of the association between cord serum PCB-153 (ng/L) and birth weight (g): Boys/Maternal non-smoking (A), Boys/Maternal smoking (B), Girls/Maternal
non-smoking (C), and Girls/Maternal smoking (D). The continuous line is the smoothed function for PCB-153 and discontinuous lines are the 95% CIs. Adjusted for cohort, maternal age at
delivery, parity, maternal pre-pregnancy BMI,maternal height, maternal education, time of sample collection, gestational age, and the square of gestational age. Cohort and PCB-153were
included as random effects. Complete case analysis excluding PCB-153 concentrations≥1180 ng/L. In all cases GAMmodels only needs 1 degree of freedom (df), i.e. the function fitted by
the model is linear.
29M. Casas et al. / Environment International 74 (2015) 23–31various studies on birth weight and other health effects (Sonneborn
et al., 2008; Wojtyniak et al., 2010). Non-Caucasian mothers from our
population had higher PCB-153 levels and lower education level, and
tended to smoke more during pregnancy compared to Caucasian
mothers. These particular characteristics of non-Caucasian mothers
and others not included in our analysis may have led to an enhanced
susceptibility in this population. Finally, we also found a greater reduc-
tion in birth weight among the highest education strata. Although we
tried to harmonize this variable among cohorts as best as possible,
there may still be country differences in educational levels and hence
it becomes difficult to draw conclusions.
Changes in the weight gain of the mother can potentially confound
the association between PCB-153 and birth weight. Pregnancy weight
gain can both increases the volume of lipids, thereby diluting PCB levels
in blood (Glynn et al., 2011), and increases the birth weight of the off-
spring (Siega-Riz et al., 2009). However, GWG can also be considered
a mediator because PCBs may act as obesogens and increase weight
(Tang-Peronard et al., 2014). In our analysis, after adjusting the model
for absolute GWG or estimated fat mass the PCB-153 coefficient was re-
duced significantly; however, a large reduction in birth weight associat-
edwith an increase in PCB-153 levels was still present, particularly after
including estimated fat mass which is a more precise surrogate of ma-
ternal lipid gain during pregnancy. The reduction was still present
after subtracting birth weight from GWG (data not shown). These find-
ings suggest that GWGmay confound this association or maybe partial-
lymediate it since a direct effect of PCB-153 on birthweight still exists. If
this is a partial mediation, we must consider the possibility of omittedmediators in the direct relationship between PCBs and birth weight
(Zhao et al., 2010). To elucidatewhether GWG is a potential confounder
or partial mediator, further studies with repeated measurements
throughout pregnancy are needed.
One of themain limitations of this study is that only one PCB conge-
ner 153 was measured in all cohorts. There are 209 PCB congeners
which differ in structure and mechanism of action and hence may
have different health outcomes (Yorita Christensen and White, 2011).
Although PCB-153 is the major PCB congener and is highly correlated
with other congeners and with the total sum of PCBs (Hagmar et al.,
2006), the magnitude of the correlations varies. In our population for
example, in cohorts where data on various PCB congeners were avail-
able, the Spearman correlation coefficients between them ranged from
0.23 to 1.00. Also, there is likely to be different mixtures of congeners
within the different cohorts. Recently, the RHEA cohort conducted a
multipollutant model including concentrations of 6 PCB congeners,
p,p′-DDE, and HCB and showed that the association with birth
weight was mainly driven by HCB (Vafeiadi et al., 2014). We did
not have HCB concentrations available at the moment of the study;
further studies should add more congeners and other persistent or-
ganic pollutants in the analysis. Moreover, in a multipollutant
model including DDT and o,p′-DDT, Kezios et al. (2013) found a
reduction in birth weight and gestational age of 153 g and 0.5 days
associated with prenatal p,p′-DDE exposure, respectively. When
DDT and o,p′-DDT were not considered, p,p′-DDE was not associated
neither with birth weight nor gestational age. However, we have to
consider that this study was done in an old population with much
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(median: 447 ng/L). Further research is needed to disentangle
whether the reduction in birth weight and the susceptible subgroups
identified could be accounted for other individual PCB congeners, for
the mixture of them or for other environmental contaminants.
We were able to harmonize common potential confounders; how-
ever, this implies the loss of someparticular and valuable cohort charac-
teristics. Differences in the coefficient of association between PCB-153
and birth weight in this paper compared to those reported by Govarts
et al. (2012) were mainly due to the increase in sample size in the
RHEA cohort: from 30 to 1115 mother–child pairs (Vafeiadi et al.,
2014). The coefficient in this cohort changed substantially from 11.27
(95% CI: −20.89, 43.44) to −0.31 (95% CI: −0.93, 0.32), which is
more consistent with the other cohorts. The strength of this study relies
on its large sample size that allowed us to better describe the shape of
the relationship and to identify effect modifiers. Compared with the
previous study (Govarts et al., 2012), we performed multiple imputa-
tion using chained equations to deal with missing values in covariates
(Spratt et al., 2010). No significant differences in covariate distributions
were shown between observed and imputed data of each dataset (PCB-
153 and birth weight dataset, Supplemental material, Table S8). Fur-
thermore, we calculated cohort-specific conversion factors rather than
general conversion factors, providing more valid comparisons of OC
measurements in the different matrices within each cohort.
5. Conclusion
This study suggests that the association between low-level exposure
to PCB-153 and birth weight exists and follows an inverse linear expo-
sure–response relationship, with effects even at low levels, and thatma-
ternal smoking and ethnicity modify this association.
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